Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous interventions--a conservative approach

Glycoprotein IIb-IIIa inhibitors in unstable coronary syndromes and percutaneous interventions--a conservative approach

Antagonists of platelet glycoprotein IIb/IIIa have an approved role in preventing acute complications and coronary events in the setting of percutaneous coronary interventions (PCI). Their use in unstable coronary syndromes out of the PCI setting is however debated. This paper summarizes reasons for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista portuguesa de cardiologia 2003-07, Vol.22 (7-8), p.995-1002
Hauptverfasser: De Caterina, Raffaele, Di Gioacchino, Lorena
Format: Artikel
Sprache:eng
Schlagworte:
Angioplasty, Balloon, Coronary
Coronary Artery Disease - therapy
Coronary Thrombosis - therapy
Humans
Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors
Syndrome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antagonists of platelet glycoprotein IIb/IIIa have an approved role in preventing acute complications and coronary events in the setting of percutaneous coronary interventions (PCI). Their use in unstable coronary syndromes out of the PCI setting is however debated. This paper summarizes reasons for the ongoing debate and highlights areas of uncertainty.
ISSN:0870-2551